Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Subscribe To Our Newsletter & Stay Updated
